A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.
A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...
The interim leader of the National Institutes of Health gave some clarification tied to Trump administrations restrictions on ...
The White House budget office rescinded the funding freeze, but Trump will still attempt to pull back funding from “woke” ...
This move comes after President Donald Trump ordered the federal government to solely recognise male and female sex and ...
At NIH, Memoli heads the Laboratory of Infectious Disease (LID) Clinical Studies Unit (CSU), where much of the research has ...
The U.S. Centers for Disease Control and Prevention and other federal health agencies on Friday took down webpages with ...
Officials at the U.S. Centers for Disease Control and Prevention and other federal health agencies are scrubbing or taking ...